Correspondent
Stocks correspondent
Hyejin Lee covers the Seoul tape. Up before the cash open. She thinks in screens, not hot takes, and she will not tell you what to buy.
Samsung Biologics shares climbed after the CDMO confirmed renewal talks with a top-tier U.S. client on Songdo capacity running through 2029, extending a order book that already cleared 5 trillion won this year.
The Kospi gave back part of its record run as a firmer dollar clipped export margins for Samsung Electronics and SK hynix, with foreign funds trimming buys ahead of Seoul’s long Chuseok weekend.